Early intravenous Beta-Blockade with esmolol in adults with severe Traumatic Brain Injury (EBB-TBI): A phase 2a intervention design study
(2023)
Journal Article
Background
Targeted beta-blockade after severe traumatic brain injury may reduce secondary brain injury by attenuating the sympathoadrenal response. The potential role and optimal dose for esmolol, a selective, short-acting, titratable beta-1 beta...
Read More about Early intravenous Beta-Blockade with esmolol in adults with severe Traumatic Brain Injury (EBB-TBI): A phase 2a intervention design study.